Skip to Content

Tetrabenazine

In the US, Tetrabenazine (tetrabenazine systemic) is a member of the drug class miscellaneous central nervous system agents and is used to treat Huntington's Disease and Tardive Dyskinesia.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AK01

CAS registry number (Chemical Abstracts Service)

0000058-46-8

Chemical Formula

C19-H27-N-O3

Molecular Weight

317

Therapeutic Categories

Treatment of Huntington's disease

Vesicular monoamine transporter 2 (VMAT2) inhibitor

Chemical Names

(RS)-2,3,4,6,7,11b-Hexahydro-3-isobutyl-9-10-dimetoxy-1H-benzo[a]chinolizin-2-on (IUPAC)

1,2,3,4,6,7-hexahydro-3-isobutyl-9,10-dimetoxy-2-oxo-11bH-benzo[a]quinolizine (WHO)

1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimetoxy-2H-benzo[a]quinolizin-2-one (WHO)

2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimetoxy-

2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimetoxy-3-(2-metylpropyl)-

2-oxo-3-isobutyl-9,10-dimetoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine

9,10-Dimetoxy-3-(2-metylpropyl)-1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizin-2-one (BAN)

Foreign Names

  • Tetrabenazinum (Latin)
  • Tetrabenazin (German)
  • TĂ©trabĂ©nazine (French)
  • Tetrabenazina (Spanish)

Generic Names

  • Tetrabenazine (OS: BAN, JAN)
  • 5-21-13-00178 (IS: Beilstein)
  • AI3-52046 (IS)
  • BRN 0040090 (IS)
  • EINECS 200-383-6 (IS)
  • NSC 169886 (IS)
  • Ro 1-9569 (IS)

Brand Names

  • Choreazine
    Alfresa Pharma, Japan
  • Feinardon
    Tuteur, Argentina
  • Motetis
    AOP, Hungary; Douglas, New Zealand
  • Nitoman
    Cambridge, Taiwan; MediLink, Denmark; Temmler, Germany; UCB, Portugal; UCB Pharma, Spain; Valeant Pharmaceuticals International, Canada
  • PMS-Tetrabenazine
    Pharmascience, Canada
  • Revocon
    Capsifar, Portugal; LENIS, Slovenia; Sun Pharmaceuticals UK, United Kingdom; Tri Healthcare, Malta
  • Tetmodis
    AOP, Bosnia & Herzegowina; AOP Orphan Pharma, Estonia; AOP Orphan Pharmaceuticals, Austria; Axon Pharma, Chile; Beacon Pharmaceuticals, United Kingdom; Bluefish, France; Campus Pharma, Denmark; CampusPharma, Sweden; Cherubino, Malta; Desitin, Germany; Desitin Arzneimittel, Latvia; Orpha Devel, Netherlands; Orpha-Devel, Lithuania; Orpha-Devel, Poland; Orpha-Devel, Romania; Orpha-Devel, Slovenia; Orphan Europe, Portugal; Providens, Croatia (Hrvatska); Trommsdorff, Bulgaria
  • Tetrabenacina Lafedar
    Lafedar, Argentina
  • Tetrabenazine
    SteriMax, Canada; Valeant, Australia
  • Tetrabenazine AOP Orphan Pharmaceuticals
    AOP Orphan Pharmaceuticals, Belgium
  • Xenazina
    Chiesi Farmaceutici, Italy
  • Xenazine
    AFT, New Zealand; Curatis, Switzerland; EUSA Pharma, France; IFET, Greece; Lifehealth Limited, Israel; Lundbeck, United States; P & D, Malta; PharmaSwiss, Netherlands; PharmaSwiss, Poland

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide